Explore more publications!

Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

Press releases published on January 15, 2026

American Oncology Research and MiBA Form Strategic Alliance to Integrate Real-Time Data Intelligence with Community-Based Clinical Research
Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants
R1 Prior Authorization, Now Powered by the Phare OS, Accelerates Care, Reduces Costs and Improves Accuracy
Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards
Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase
Colorado, Montana, and Utah Among Nation’s Top States in RSV Protection for Babies Following Intermountain Health Awareness Effort
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia
Verano Announces Agreement to Upsize Revolving Credit Facility Commitment to $100,000,000 and Extend Maturity Date
Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference
Digbi Health Publishes Peer-Reviewed Data Demonstrating Significant Cost Savings for Employers Via Its Precision Biology Telehealth Platform to Manage GLP-1, Metabolic, and GI Costs
Verdane Invests in Clue to Accelerate the Future of Women’s Health
Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market
Press Release: Myqorzo and Redemplo approved in China
Communiqué de presse : Myqorzo et Redemplo approuvés en Chine
Santhera erhält Swissmedic-Zulassung für AGAMREE® (Vamorolon) zur Behandlung von Duchenne-Muskeldystrophie
Santhera Receives Swissmedic Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions